Efficacy and safety of efgartigimod as an add-on therapy in patients with NMOSD and MOGAD at the acute attack phase. [PDF]
Yin W, Wang S, Lu W, Duan T.
europepmc +1 more source
Efficacy of Ravulizumab During the Acute Phase of Neuromyelitis Optica Spectrum Disorder. [PDF]
Tsuzaki K +5 more
europepmc +1 more source
Satralizumab in the management of aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder during pregnancy: a case report. [PDF]
Ding M +5 more
europepmc +1 more source
Large language models as clinical decision-support tools in multiple sclerosis and neuromyelitis optica spectrum disorders: A comparative study of ChatGPT-4o and neurologists. [PDF]
Saposnik G +11 more
europepmc +1 more source
Paraneoplastic Neuromyelitis Optica Spectrum Disorder Associated With Ascending Colon Cancer Expressing Aquaporin-4 and Glucose-Regulated Protein 78. [PDF]
Iwamoto R +4 more
europepmc +1 more source
Analysis of MOG-IgG and AQP4-IgG Serology, Demographics, and Seasonality From Large Neuroimmunology Laboratory Registry and Clinical Cohorts. [PDF]
Vorasoot N +13 more
europepmc +1 more source
Erratum: Wavenumber-space wavefront sensorless adaptive-optics for optical coherence tomography: publisher's note. [PDF]
Ruiz-Lopera S +3 more
europepmc +1 more source
Causal Exposures of Immune Cells in Neuromyelitis Optica Spectrum Disorders: A Mendelian Randomization Study and Flow Cytometry Analysis. [PDF]
Ren J +8 more
europepmc +1 more source
Stereological Assessment of Locus Coeruleus in the Mouse: A Methodological Study in Pups and Adult Animals. [PDF]
Scotto M +5 more
europepmc +1 more source
Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis. [PDF]
Furlan R +28 more
europepmc +1 more source

